CCR5AS
gene geneOn this page
Summary
CCR5AS (CCR5 antisense RNA, HGNC:54398) is a long non-coding RNA gene on chromosome 3p21.31.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:54398 |
| Approved symbol | CCR5AS |
| Name | CCR5 antisense RNA |
| Location | 3p21.31 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000223552 |
| Ensembl biotype | lncRNA |
| Entrez | 102724297 |
| RNAcentral | URS00026A1C41 — lncRNA, 1634 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 25 lncRNA
ENST00000451485, ENST00000686150, ENST00000691693, ENST00000701066, ENST00000701879, ENST00000717843, ENST00000717844, ENST00000717851, ENST00000717852, ENST00000717853, ENST00000717854, ENST00000717855, ENST00000741266, ENST00000741267, ENST00000741268, ENST00000741269, ENST00000741270, ENST00000741271, ENST00000741272, ENST00000741273, ENST00000741274, ENST00000741275, ENST00000741276, ENST00000741277, ENST00000741278
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000451485 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001603846 | 46363984 | 46365045 |
| ENSE00001674136 | 46392825 | 46393052 |
| ENSE00001704648 | 46406897 | 46407066 |
| ENSE00001740682 | 46371244 | 46371417 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 75.90.
FANTOM5 (CAGE): breadth broad, TPM avg 1.6980 / max 112.0451, expressed in 260 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 41971 | 1.1880 | 208 |
| 41974 | 0.1492 | 40 |
| 41970 | 0.1063 | 39 |
| 41972 | 0.1027 | 48 |
| 41973 | 0.0933 | 35 |
| 41975 | 0.0586 | 28 |
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 75.90 | gold quality |
| monocyte | CL:0000576 | 75.58 | gold quality |
| leukocyte | CL:0000738 | 74.60 | gold quality |
| vermiform appendix | UBERON:0001154 | 70.84 | gold quality |
| blood | UBERON:0000178 | 70.27 | gold quality |
| right lung | UBERON:0002167 | 69.85 | gold quality |
| granulocyte | CL:0000094 | 69.61 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 66.44 | gold quality |
| duodenum | UBERON:0002114 | 65.75 | gold quality |
| lung | UBERON:0002048 | 65.52 | gold quality |
| rectum | UBERON:0001052 | 64.70 | gold quality |
| sural nerve | UBERON:0015488 | 64.22 | silver quality |
| tonsil | UBERON:0002372 | 63.06 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 62.39 | gold quality |
| gall bladder | UBERON:0002110 | 62.22 | gold quality |
| quadriceps femoris | UBERON:0001377 | 61.63 | gold quality |
| lymph node | UBERON:0000029 | 61.10 | gold quality |
| spleen | UBERON:0002106 | 60.82 | gold quality |
| muscle tissue | UBERON:0002385 | 58.80 | gold quality |
| islet of Langerhans | UBERON:0000006 | 58.77 | gold quality |
| cerebellar vermis | UBERON:0004720 | 58.50 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 57.97 | gold quality |
| thymus | UBERON:0002370 | 57.29 | silver quality |
| placenta | UBERON:0001987 | 56.67 | gold quality |
| prefrontal cortex | UBERON:0000451 | 56.09 | gold quality |
| bone marrow | UBERON:0002371 | 55.73 | gold quality |
| spinal cord | UBERON:0002240 | 55.67 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 55.65 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 55.47 | gold quality |
| endometrium | UBERON:0001295 | 55.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- CCR5AS interfered with interactions between the RNA-binding protein Raly and the CCR5 3’ untranslated region, protecting CCR5 messenger RNA from Raly-mediated degradation. Reduction in CCR5 expression through inhibition of CCR5AS diminished infection of CD4(+) T cells with CCR5-tropic HIV in vitro. (PMID:31209403)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): susceptibility to HIV infection